Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir for HCV Genotype 6
NCT02480166Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Harvoni in hepatitis C virus infection, sponsored by Stanford University. Started Jun 2015; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02480166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480166.